Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Buratti

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
American Journal of Hematology|February 24, 2006
Monolateral renal infarction and erythromelalgia in a case of chronic myelogenous leukemiaKarin Bernardini, Andrea Judith Lanthaler, Thomas Buratti, et al.
Journal of Neurology|July 28, 2005
Corticospinal involvement in patients with a portosystemic shunt due to liver cirrhosis: a MEP studyRaffaele Nardone, Thomas Buratti, Antonio Oliviero, et al.
Annals of Hematology|March 7, 2020
Clinical outcomes and prognostic factors in patients with multiple myeloma in South Tyrol: a retrospective single-center analysisMaximilian Mair, Christian Straka, Thomas Buratti, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 22, 2006
Bactobilia after liver transplantation: frequency and antibiotic susceptibilityGunda Millonig, Thomas Buratti, Ivo W Graziadei, et al.
Onkologie|May 8, 2009
Delayed oxaliplatin-induced sensorimotor polyneuropathyRaffaele Nardone, Thomas Buratti, Stefan Golaszewski, et al.
BMC Cancer|May 8, 2015
Soluble EpCAM levels in ascites correlate with positive cytology and neutralize catumaxomab activity in vitroAndreas Seeber, Agnieszka Martowicz, Gilbert Spizzo, et al.
Onkologie|March 2, 2011
Clinical aspects, diagnostic challenges and management of patients with neuroendocrine tumors (NETs)Gilbert Spizzo, Karin Bernardini, Oreste Pieramico, et al.
European Journal of Cancer (Oxford, England : 1990)|March 6, 2022
Third dose of SARS-CoV-2 vaccination in hemato-oncological patients and health care workers: immune responses and adverse events - a retrospective cohort studyMaximilian J Mair, Julia M Berger, Manfred Mitterer, et al.
Cancer Cell|April 16, 2022
Enhanced SARS-CoV-2 breakthrough infections in patients with hematologic and solid cancers due to OmicronMaximilian J Mair, Manfred Mitterer, Pia Gattinger, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
American Journal of Hematology|February 24, 2006
Monolateral renal infarction and erythromelalgia in a case of chronic myelogenous leukemiaKarin Bernardini, Andrea Judith Lanthaler, Thomas Buratti, et al.
Journal of Neurology|July 28, 2005
Corticospinal involvement in patients with a portosystemic shunt due to liver cirrhosis: a MEP studyRaffaele Nardone, Thomas Buratti, Antonio Oliviero, et al.
Annals of Hematology|March 7, 2020
Clinical outcomes and prognostic factors in patients with multiple myeloma in South Tyrol: a retrospective single-center analysisMaximilian Mair, Christian Straka, Thomas Buratti, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 22, 2006
Bactobilia after liver transplantation: frequency and antibiotic susceptibilityGunda Millonig, Thomas Buratti, Ivo W Graziadei, et al.
Onkologie|May 8, 2009
Delayed oxaliplatin-induced sensorimotor polyneuropathyRaffaele Nardone, Thomas Buratti, Stefan Golaszewski, et al.
BMC Cancer|May 8, 2015
Soluble EpCAM levels in ascites correlate with positive cytology and neutralize catumaxomab activity in vitroAndreas Seeber, Agnieszka Martowicz, Gilbert Spizzo, et al.
Onkologie|March 2, 2011
Clinical aspects, diagnostic challenges and management of patients with neuroendocrine tumors (NETs)Gilbert Spizzo, Karin Bernardini, Oreste Pieramico, et al.
European Journal of Cancer (Oxford, England : 1990)|March 6, 2022
Third dose of SARS-CoV-2 vaccination in hemato-oncological patients and health care workers: immune responses and adverse events - a retrospective cohort studyMaximilian J Mair, Julia M Berger, Manfred Mitterer, et al.
Cancer Cell|April 16, 2022
Enhanced SARS-CoV-2 breakthrough infections in patients with hematologic and solid cancers due to OmicronMaximilian J Mair, Manfred Mitterer, Pia Gattinger, et al.
Pageof 1